Business Context and Reporting Period
Company: BIO-RAD LABORATORIES, INC.
Filing Type: Form 8-K (Current Report)
Date of Report: November 3, 2015
Event: Amendment and restatement of the Company's Code of Business Ethics and Conduct.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is a current report regarding corporate governance updates.
Material Changes
The Company announced an amended and restated Code of Business Ethics and Conduct (the "Code") effective November 3, 2015. Key changes include:
- Enhanced readability and a more user-friendly format for workforce members.
- Greater detail on existing topics and the inclusion of practical questions and answers.
- References to other Bio-Rad policies and procedures.
- Addressing of new topics, including:
- Interacting with healthcare professionals and organizations.
- Competitor information.
- Research and development.
- Product quality and safety.
- Money laundering.
- Safeguarding company assets and reputation.
- Charitable contributions and community impact.
- Communicating with media and investors.
- Political activities.
- Updates to provisions regarding seeking guidance and reporting concerns.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary on business performance. It does not disclose specific risks or contingencies beyond the general scope of the updated Code of Ethics. The Company intends to disclose future amendments or waivers of the Code by posting them to its website.
Key Facts for Investor Verification
- Verify the full text of the amended Code of Business Ethics and Conduct attached as Exhibit 14.1.
- Confirm the availability of the Code on the Corporate Governance section of the Company's website (www.bio-rad.com).
- Note that future amendments or waivers will be disclosed via the Company's website rather than immediate 8-K filings.